Timothy Easley/AFP via Getty Images
White House COVID-19 Response Coordinator Jeff Zients says a pause on the use of the Johnson & Johnson COVID-19 vaccine won't have a "significant impact" on the country's vaccination plan.
"Johnson & Johnson vaccine makes up less than 5 percent of the recorded shots in arms in the United States to date," he said in a statement. "Based on actions taken by the President earlier this year, the United States has secured enough Pfizer and Moderna doses for 300 million Americans."
"Over the last few weeks, we have made available more than 25 million doses of Pfizer and Moderna each week, and in fact this week we will make available 28 million doses of these vaccines," he added. "This is more than enough supply to continue the current pace of vaccinations of 3 million shots per day, and meet the President's goal of 200 million shots by his 100th day in office-and continue on to reach every adult who wants to be vaccinated."
This is a developing story. Please check back for more updates.